AE Wealth Management’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$239K Buy
+6,437
New +$382K ﹤0.01% 1695

Other funds holding XENE

AE Wealth Management's XENE Position: Q3 2026 in Review

AE Wealth Management opened a new position in Xenon Pharmaceuticals (XENE) in Q3 2026: 6,437 shares worth $239K. The stake represents ﹤0.01% of the portfolio and ranks #1695 among its holdings.

286 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • AE Wealth Management held 6,437 shares of Xenon Pharmaceuticals worth $239K as of Q3 2026.
  • Xenon Pharmaceuticals was a new AE Wealth Management position in Q3 2026.
  • Xenon Pharmaceuticals made up ﹤0.01% of AE Wealth Management's portfolio in Q3 2026, its #1695 holding.
  • 286 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on AE Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.